These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5964006)

  • 61. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 62. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 63. [Results of the use of a live measles vaccine prepared from the Leningrad-16 strain].
    Taros LIu; Boĭchuk LM; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():57-77. PubMed ID: 5860963
    [No Abstract]   [Full Text] [Related]  

  • 64. The antigenic effect of measles vaccine in infants and young children.
    Henigst W; Müller F
    Ger Med Mon; 1967 Feb; 12(2):59-61. PubMed ID: 6044990
    [No Abstract]   [Full Text] [Related]  

  • 65. [Activities of immune globulins at the time of measles vaccine inoculation and measles infection, with special reference to sensitivity and resistance of the antibody to 2-mercaptoethanol].
    Arai M; Nakamura M
    Nihon Shonika Gakkai Zasshi; 1969 Dec; 73(12):2032-7. PubMed ID: 4191839
    [No Abstract]   [Full Text] [Related]  

  • 66. [Experiences with the live measles virus vaccines L-4 and L-16 in the German Democratic Republic].
    Starke G
    Pathol Microbiol (Basel); 1965; 28(6):950-5. PubMed ID: 5879805
    [No Abstract]   [Full Text] [Related]  

  • 67. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combined inoculation of inactivated and attenuated measles vaccines].
    Shih A
    Nihon Shonika Gakkai Zasshi; 1969 Jul; 73(7):1003-10. PubMed ID: 5390046
    [No Abstract]   [Full Text] [Related]  

  • 69. [Studies on biological, reactogenic and immunogenic properties of a new variant of a live measles vaccine prepared from the Leningrad-5 strain].
    Denisov GM; Boĭchuk LM; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():78-86. PubMed ID: 5860964
    [No Abstract]   [Full Text] [Related]  

  • 70. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Studies on the epidemiological effectiveness in Kirghizia of a live measles vaccine prepared from the Leningrad-4 strain].
    Aminova MG; Cheredova NG; Novokreshchenova FA; Atakhanov KA; Aĭdaraliev KhA; Asankhodzhoev DD
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():335-45. PubMed ID: 4221934
    [No Abstract]   [Full Text] [Related]  

  • 72. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vacceination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):651-67. PubMed ID: 5400784
    [No Abstract]   [Full Text] [Related]  

  • 74. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 75. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
    al-Attar I; Reisman J; Muehlmann M; McIntosh K
    Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
    [No Abstract]   [Full Text] [Related]  

  • 76. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 2. Clinical reactions with combination of inactivated raw vaccine and blood antibody value].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):16-20. PubMed ID: 5691552
    [No Abstract]   [Full Text] [Related]  

  • 77. [Reactivity to live measles vaccine of the ESHCH strain of the Academy of Medical Sciences, RSFS].
    Tsipershteĭn MIa
    Pediatr Akus Ginekol; 1970; 4():25-6. PubMed ID: 5504822
    [No Abstract]   [Full Text] [Related]  

  • 78. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 79. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.